Euro
British Pound
US Dollar
PD-L1 Antibody |
|||
| 49251-50ul | SAB | 50ul |
|
PD-L1 Antibody |
|||
| P1013-01m | SAB | 0.1m |
|
PD-L1 Antibody |
|||
| P1013-1ml | SAB | 1ml |
|
PD-L1 Conjugated Antibody |
|||
| C49251 | SAB | 100ul |
|
Anti-PD-L1 Antibody |
|||
| A1454-100 | Biovision |
|
|
Anti-PD-L1 Antibody |
|||
| A1454-30T | Biovision |
|
|
Mouse PD-L1 Antibody |
|||
| 32903-05111 | AssayPro | 150 ug |
|
Anti-PD-L1 antibody |
|||
| STJ130022 | St John's Laboratory | 50 µl |
|
|
Description: Programmed death-ligand 1 (PD-L1) is a 40kDa type 1 transmembrane protein that suppresses immune system. PD-L1 is expressed in hematopoietic and nonhematopoietic cells including T cells and B cells and various types of tumor cells. PD-L1 binds to its receptor Programmed death 1 (PD1). During infection or inflammation, PD1PD-L1 interaction is important for preventing autoimmunity. In tumor microenvironments, PD1-PD-L1 interaction provides an immune escape for tumor cells through cytotoxic T-cell inactivation. Expression of this gene in tumor cells is considered to be prognostic in many types of human cancers. In recent years, PDL1 has become an important biomarker and immunotherapy target for many types of malignancies.
|
|||
Anti-PD-L1 antibody |
|||
| STJ130023 | St John's Laboratory | 50 µl |
|
|
Description: Programmed death-ligand 1 (PD-L1) is a 40kDa type 1 transmembrane protein that suppresses immune system. PD-L1 is expressed in hematopoietic and nonhematopoietic cells including T cells and B cells and various types of tumor cells. PD-L1 binds to its receptor Programmed death 1 (PD1). During infection or inflammation, PD1PD-L1 interaction is important for preventing autoimmunity. In tumor microenvironments, PD1-PD-L1 interaction provides an immune escape for tumor cells through cytotoxic T-cell inactivation. Expression of this gene in tumor cells is considered to be prognostic in many types of human cancers. In recent years, PDL1 has become an important biomarker and immunotherapy target for many types of malignancies.
|
|||
Anti-PD-L1 antibody |
|||
| STJ130024 | St John's Laboratory | 50 µl |
|
|
Description: Programmed death-ligand 1 (PD-L1) is a 40kDa type 1 transmembrane protein that suppresses immune system. PD-L1 is expressed in hematopoietic and nonhematopoietic cells including T cells and B cells and various types of tumor cells. PD-L1 binds to its receptor Programmed death 1 (PD1). During infection or inflammation, PD1PD-L1 interaction is important for preventing autoimmunity. In tumor microenvironments, PD1-PD-L1 interaction provides an immune escape for tumor cells through cytotoxic T-cell inactivation. Expression of this gene in tumor cells is considered to be prognostic in many types of human cancers. In recent years, PDL1 has become an important biomarker and immunotherapy target for many types of malignancies.
|
|||
Anti-PD-L1 antibody |
|||
| STJ180217 | St John's Laboratory | 0.1 ml |
|
Anti-PD-L1 antibody |
|||
| STJ180383 | St John's Laboratory | 0.1 ml |
|
Anti-PD-L1 antibody |
|||
| STJ190082 | St John's Laboratory | 200 µl |
|
|
Description: Unconjugated Mouse monoclonal to PD-L1 (AS1A7)
|
|||
PD-L1, CD274 |
|||
| E6TA00108 | EnoGene | 0.1mg |
|
PD-L1 Protein |
|||
| 20-abx261703 | Abbexa |
|
|
|
|||
PD-L1 Protein |
|||
| 20-abx263458 | Abbexa |
|
|
|
|||
Anti-PD-L1 |
|||
| DB-241-0.1 | DB Biotech | 100 μl |
|
|
Description: rabbit monospecific clonal antibodies for ihc-p application; concentrated
|
|||
Anti-PD-L1 |
|||
| DB-241-0.2 | DB Biotech | 200 μl |
|
|
Description: rabbit monospecific clonal antibodies for ihc-p application; concentrated
|
|||
Anti-PD-L1 |
|||
| DB-241-0.5 | DB Biotech | 500 μl |
|
|
Description: rabbit monospecific clonal antibodies for ihc-p application; concentrated
|
|||
Anti-PD-L1 |
|||
| DB-241-1 | DB Biotech | 1 ml |
|
|
Description: rabbit monospecific clonal antibodies for ihc-p application; concentrated
|
|||
Anti-PD-L1 |
|||
| DB-241-RTU-15 | DB Biotech | 15 ml |
|
|
Description: rabbit monospecific clonal antibodies for ihc-p application; prediluted (ready to use)
|
|||
Anti-PD-L1 |
|||
| DB-241-RTU-7 | DB Biotech | 7 ml |
|
|
Description: rabbit monospecific clonal antibodies for ihc-p application; prediluted (ready to use)
|
|||
Anti-PD-L1 |
|||
| DB241-RTU-15 | DB Biotech | 15 ml |
|
|
Description: rabbit monospecific clonal antibodies for ihc-p application; prediluted (ready to use)
|
|||
Anti-PD-L1 |
|||
| DB241-RTU-7 | DB Biotech | 7 ml |
|
|
Description: rabbit monospecific clonal antibodies for ihc-p application; prediluted (ready to use)
|
|||
PD-1/PD-L1 inhibitor 2 |
|||
| B6023-25 | ApexBio | 25 mg |
|
|
Description: PD-1/PD-L1 inhibitor 2 is a PD-1/PD-L1 interaction inhibitor.
|
|||
PD-1/PD-L1 inhibitor 2 |
|||
| B6023-5 | ApexBio | 5 mg |
|
|
Description: PD-1/PD-L1 inhibitor 2 is a PD-1/PD-L1 interaction inhibitor.
|
|||
PD-1/PD-L1 inhibitor 1 |
|||
| B6172-25 | ApexBio | 25 mg |
|
|
Description: IC50: 0.006-0.10 ?MPD-1/PD-L1 inhibitor 1 is a PD-1/PD-L1 interaction inhibitor.Plenty of studies show that blocking the PD-1/PD-Ll interactions can lead to the restorage and augment of T cell activation in many systems.
|
|||
PD-1/PD-L1 inhibitor 1 |
|||
| B6172-5 | ApexBio | 5 mg |
|
|
Description: IC50: 0.006-0.10 ?MPD-1/PD-L1 inhibitor 1 is a PD-1/PD-L1 interaction inhibitor.Plenty of studies show that blocking the PD-1/PD-Ll interactions can lead to the restorage and augment of T cell activation in many systems.
|
|||
PD-1/PD-L1 Inhibitor 2 |
|||
| B1050-25 | Biovision |
|
|
PD-1/PD-L1 Inhibitor 2 |
|||
| B1050-5 | Biovision |
|
|
PD-1/PD-L1 Inhibitor 1 |
|||
| B1213-25 | Biovision |
|
|
anti- PD-L1/CD274 antibody |
|||
| FNab06280 | FN Test | 100µg |
|
|
|||
|
Description: Antibody raised against PD-L1/CD274
|
|||
anti- PD-L1/CD274 antibody |
|||
| FNab06281 | FN Test | 100µg |
|
|
|||
|
Description: Antibody raised against PD-L1/CD274
|
|||
)
Anti-PD-L1 Antibody (IHC411) |
|||
| A1549-50 | Biovision |
|
|
Anti-PD-L1/CD274 Antibody |
|||
| PB9994 | BosterBio | 100ug/vial |
|
Anti-PD-L1/CD274 Antibody |
|||
| PB9154 | BosterBio | 100ug/vial |
|
Anti-PD-L1/CD274 antibody |
|||
| PAab06280 | Lifescience Market | 100 ug |
|
Anti-PD-L1/CD274 Antibody |
|||
| PA1851 | BosterBio | 100ug/vial |
|
Anti-CD274 / PD-L1 antibody |
|||
| STJ70646 | St John's Laboratory | 100 µg |
|
Ribosome-inactivating protein PD-L1 / PD-L2 Antibody |
|||
| 20-abx319445 | Abbexa |
|
|
|
|||
Ribosome-inactivating protein PD-L1/PD-L2 Antibody |
|||
| 1-CSB-PA306294LA01PJJ | Cusabio |
|
|
|
|||
|
Description: A polyclonal antibody against Ribosome-inactivating protein PD-L1/PD-L2. Recognizes Ribosome-inactivating protein PD-L1/PD-L2 from Phytolacca dioica. This antibody is Unconjugated. Tested in the following application: ELISA
|
|||
B7-H1/PD-L1 |
|||
| E21-315 | EnoGene | 10ug |
|
PD-L1 Blocking Peptide |
|||
| 20-abx161326 | Abbexa |
|
|
|
|||
%20siRNA)
PD-L1 (CD274) siRNA |
|||
| 20-abx910978 | Abbexa |
|
|
|
|||